Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0002014509-26-000003
Filing Date
2026-03-26
Accepted
2026-03-26 17:37:09
Documents
1
Period of Report
2026-03-25

Document Format Files

Seq Description Document Type Size
1 form4-03262026_090305.html 4  
1 form4-03262026_090305.xml 4 4234
  Complete submission text file 0002014509-26-000003.txt   5804
Mailing Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404
Business Address 919 EAST HILLSDALE BOULEVARD SUITE 250 FOSTER CITY CA 94404 6504737700
GERON CORP (Issuer) CIK: 0000886744 (see all company filings)

EIN.: 752287752 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O APPLIED THERAPEUTICS, INC. 545 FIFTH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address
Chinoporos Constantine (Reporting) CIK: 0002014509 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20859 | Film No.: 26799645